Increased plasma level of apelin with NYHA grade II and III but not IV
- 9 May 2020
- journal article
- research article
- Published by Springer Nature in Amino Acids
- Vol. 52 (5) , 823-829
Abstract
The change in plasma apelin level in heart failure (HF) patients is controversial. We investigated the change in plasma apelin level in HF patients versus control and non-HF patients. The plasma level of apelin was measured by ELISA and plasma level of B-type natriuretic peptide (BNP) by fluorescence immunoassay. We included 101 patients with HF, 32 patients without HF and 20 controls. The three groups did not differ in general and clinical characteristics. Plasma levels of apelin and BNP were both higher in HF patients than non-HF patients and controls. Plasma levels of apelin and BNP were not correlated. Plasma level of BNP was increased with increasing New York Heart Association grade and apelin level was decreased. Apelin level was lower in HF patients with NYHA grade IV than in controls and non-HF patients. Apelin level had 75% diagnostic value for HF, and BNP level had 96.8% diagnostic value. At a cutoff of 6.44 ng/mL apelin level, sensitivity was 69.3%, and specificity 97.1%. However, the diagnostic of apelin for NYHA II patients was higher than that of BNP (99.6% vs. 96.1%). These results suggested that apelin might be particularly useful in association with BNP in mild HF patients.Keywords
Funding Information
- National Natural Science Foundation of China (81670434, 81770499, 31872790)
- Project for training excellent talents of Xicheng District in Beijing (80004126)
This publication has 33 references indexed in Scilit:
- Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin AnaloguesJournal of the American Heart Association, 2013
- Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure, 2013
- Aliskiren, ALTITUDE, and the Implications for ATMOSPHEREEuropean Journal of Heart Failure, 2012
- Reduced circulating apelin in essential hypertension and its association with cardiac dysfunctionJournal Of Hypertension, 2011
- Transcardiac gradients of circulating apelin: extraction by normal hearts vs. release by hearts failing due to pressure overloadJournal of Applied Physiology, 2010
- Myocardial Apelin Production is Reduced in Humans With Left Ventricular Systolic DysfunctionJournal of Cardiac Failure, 2010
- Acute Cardiovascular Effects of Apelin in HumansCirculation, 2010
- Increased Apelin following Bone Marrow Mononuclear Cell Transplantation Contributes to the Improvement of Cardiac Function in Patients with Severe Heart FailureCell Transplantation, 2009
- Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary diseaseEuropean Heart Journal, 2005
- Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac ContractilityCirculation Research, 2002